These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 16258002

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells.
    Zhang LP, Takahara T, Yata Y, Furui K, Jin B, Kawada N, Watanabe A.
    J Hepatol; 1999 Oct; 31(4):703-11. PubMed ID: 10551395
    [Abstract] [Full Text] [Related]

  • 23. TRPM7 restrains plasmin activity and promotes transforming growth factor-β1 signaling in primary human lung fibroblasts.
    Zeitlmayr S, Zierler S, Staab-Weijnitz CA, Dietrich A, Geiger F, Horgen FD, Gudermann T, Breit A.
    Arch Toxicol; 2022 Oct; 96(10):2767-2783. PubMed ID: 35864199
    [Abstract] [Full Text] [Related]

  • 24. Transforming growth factor-beta1 inhibits tumor growth in a mouse melanoma model by down-regulating the plasminogen activation system.
    Ramont L, Pasco S, Hornebeck W, Maquart FX, Monboisse JC.
    Exp Cell Res; 2003 Nov 15; 291(1):1-10. PubMed ID: 14597403
    [Abstract] [Full Text] [Related]

  • 25. PAI-1 secretion and matrix deposition in human peritoneal mesothelial cell cultures: transcriptional regulation by TGF-beta 1.
    Rougier JP, Guia S, Hagège J, Nguyen G, Ronco PM.
    Kidney Int; 1998 Jul 15; 54(1):87-98. PubMed ID: 9648067
    [Abstract] [Full Text] [Related]

  • 26. Plasmin plays a key role in the regulation of profibrogenic molecules in hepatic stellate cells.
    Martínez-Rizo A, Bueno-Topete M, González-Cuevas J, Armendáriz-Borunda J.
    Liver Int; 2010 Feb 15; 30(2):298-310. PubMed ID: 19889106
    [Abstract] [Full Text] [Related]

  • 27. Studies on the mechanisms of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents.
    Longstaff C.
    Blood Coagul Fibrinolysis; 1994 Aug 15; 5(4):537-42. PubMed ID: 7531000
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Thrombospondin (TSP) and transforming growth factor beta 1 (TGF-beta) promote human A549 lung carcinoma cell plasminogen activator inhibitor type 1 (PAI-1) production and stimulate tumor cell attachment in vitro.
    Albo D, Arnoletti JP, Castiglioni A, Granick MS, Solomon MP, Rothman VL, Tuszynski GP.
    Biochem Biophys Res Commun; 1994 Sep 15; 203(2):857-65. PubMed ID: 8093068
    [Abstract] [Full Text] [Related]

  • 30. Effect of transforming growth factor-beta on the plasminogen activator system in cultured first trimester human cytotrophoblasts.
    Graham CH.
    Placenta; 1997 Sep 15; 18(2-3):137-43. PubMed ID: 9089774
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Glutathione regulates transforming growth factor-beta-stimulated collagen production in fibroblasts.
    Liu RM, Liu Y, Forman HJ, Olman M, Tarpey MM.
    Am J Physiol Lung Cell Mol Physiol; 2004 Jan 15; 286(1):L121-8. PubMed ID: 12959930
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Effects of transforming growth factor-beta 1 and phorbol ester on PAI-1 and PA genes in human lung cells.
    Jakowlew SB, Mariano JM, You L.
    Growth Factors; 1997 Jan 15; 14(2-3):177-97. PubMed ID: 9255608
    [Abstract] [Full Text] [Related]

  • 37. Plasminogen activator inhibitor 1 expression is regulated by the inflammatory mediators interleukin-1alpha, tumor necrosis factor-alpha, transforming growth factor-beta and oncostatin M in human cardiac myocytes.
    Macfelda K, Weiss TW, Kaun C, Breuss JM, Zorn G, Oberndorfer U, Voegele-Kadletz M, Huber-Beckmann R, Ullrich R, Binder BR, Losert UM, Maurer G, Pacher R, Huber K, Wojta J.
    J Mol Cell Cardiol; 2002 Dec 15; 34(12):1681-91. PubMed ID: 12505065
    [Abstract] [Full Text] [Related]

  • 38. Opposite and independent actions of cyclic AMP and transforming growth factor beta in the regulation of type 1 plasminogen activator inhibitor expression.
    Thalacker FW, Nilsen-Hamilton M.
    Biochem J; 1992 Nov 01; 287 ( Pt 3)(Pt 3):855-62. PubMed ID: 1332686
    [Abstract] [Full Text] [Related]

  • 39. A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis.
    Huang Y, Haraguchi M, Lawrence DA, Border WA, Yu L, Noble NA.
    J Clin Invest; 2003 Aug 01; 112(3):379-88. PubMed ID: 12897205
    [Abstract] [Full Text] [Related]

  • 40. Modulation of expression of monocyte/macrophage plasminogen activator activity and its implications for attenuation of vasculopathy.
    Lundgren CH, Sawa H, Sobel BE, Fujii S.
    Circulation; 1994 Oct 01; 90(4):1927-34. PubMed ID: 7923681
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.